{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:01:17Z","timestamp":1780358477054,"version":"3.54.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1097\/md.0000000000010850","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T18:21:26Z","timestamp":1527099686000},"page":"e10850","source":"Crossref","is-referenced-by-count":8,"title":["Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention"],"prefix":"10.1097","volume":"97","author":[{"given":"Sigan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-58-20210226","first-page":"e574","article-title":"2011\u200aACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"R2-58-20210226","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1161\/CIRCULATIONAHA.111.023366","article-title":"Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON","volume":"123","author":"Raber","year":"2011","journal-title":"Circulation"},{"key":"R3-58-20210226","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"R4-58-20210226","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2011.09.014","article-title":"Potential mechanisms of the acute coronary syndrome presentation in patients with the coronary slow flow phenomenon: insight from a plasma proteomic approach","volume":"156","author":"Kopetz","year":"2012","journal-title":"Int J Cardiol"},{"key":"R5-58-20210226","doi-asserted-by":"crossref","first-page":"e1438","DOI":"10.1097\/MD.0000000000001438","article-title":"Impact of early ST-Segment changes on cardiac magnetic resonance-verified intramyocardial haemorrhage and microvascular obstruction in ST-elevation myocardial infarction patients","volume":"94","author":"Ding","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R6-58-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosis.2010.11.019","article-title":"Gender differences in epicardial and tissue-level reperfusion in patients undergoing primary angioplasty for acute myocardial infarction","volume":"215","author":"Pu","year":"2011","journal-title":"Atherosclerosis"},{"key":"R7-58-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03337726","article-title":"Comparison of epicardial and myocardial perfusions after primary coronary angioplasty for ST-elevation myocardial infarction in patients under and over 75 years of age","volume":"22","author":"Pu","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"R8-58-20210226","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/hrt.2010.201889","article-title":"Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy","volume":"96","author":"Smit","year":"2010","journal-title":"Heart"},{"key":"R9-58-20210226","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehp118","article-title":"Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials","volume":"30","author":"De Luca","year":"2009","journal-title":"Eur Heart J"},{"key":"R10-58-20210226","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"R11-58-20210226","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013\u200aACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"key":"R12-58-20210226","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3892\/etm.2015.2401","article-title":"Effects of different routes of tirofiban injection on the left ventricular function and prognosis of patients with myocardial infarction treated with percutaneous coronary intervention","volume":"9","author":"Zhao","year":"2015","journal-title":"Exp Ther Med"},{"key":"R13-58-20210226","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ccd.22298","article-title":"TIMI myocardial perfusion frame count: a new method to assess myocardial perfusion and its predictive value for short-term prognosis","volume":"75","author":"Ding","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R14-58-20210226","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10554-015-0834-4","article-title":"Influence of microvascular dysfunction on regional myocardial deformation post-acute myocardial infarction: insights from a novel angiographic index for assessing myocardial tissue-level reperfusion","volume":"32","author":"He","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"R15-58-20210226","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2015.10.194","article-title":"Frame counting improves the assessment of post-reperfusion microvascular patency by TIMI myocardial perfusion grade: evidence from cardiac magnetic resonance imaging","volume":"203","author":"Ge","year":"2016","journal-title":"Int J Cardiol"},{"key":"R16-58-20210226","first-page":"2909","article-title":"Eur Heart","volume":"32","year":"2011","journal-title":"J"},{"key":"R17-58-20210226","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.jacc.2014.02.576","article-title":"Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments","volume":"63","author":"Pu","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R18-58-20210226","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/eurheartj\/ehr387","article-title":"In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy","volume":"33","author":"Pu","year":"2012","journal-title":"Eur Heart J"},{"key":"R19-58-20210226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/jpi.12175","article-title":"A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases","volume":"57","author":"Yang","year":"2014","journal-title":"J Pineal Res"},{"key":"R20-58-20210226","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jpi.12312","article-title":"The nuclear melatonin receptor RORalpha is a novel endogenous defender against myocardial ischemia\/reperfusion injury","volume":"60","author":"He","year":"2016","journal-title":"J Pineal Res"},{"key":"R21-58-20210226","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jpi.12161","article-title":"Melatonin receptor-mediated protection against myocardial ischemia\/reperfusion injury: role of SIRT1","volume":"57","author":"Yu","year":"2014","journal-title":"J Pineal Res"},{"key":"R22-58-20210226","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.yjmcc.2011.06.009","article-title":"Coronary no reflow","volume":"52","author":"Schwartz","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"R23-58-20210226","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"R24-58-20210226","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1755-5922.12004","article-title":"Efficacy and safety of standard-dose versus half-dose tirofiban in patients with non-ST elevation acute coronary syndromes undergoing early percutaneous coronary intervention","volume":"31","author":"Li","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"R25-58-20210226","first-page":"873","article-title":"Factors affecting thrombolysis in myocardial infarction myocardial perfusion frame count: insights of myocardial tissue-level reperfusion from a novel index for assessing myocardial perfusion","volume":"124","author":"Pu","year":"2011","journal-title":"Chin Med J (Engl"},{"key":"R26-58-20210226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/2048872613514013","article-title":"Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600\u200amg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register","volume":"3","author":"Mrdovic","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R27-58-20210226","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12928-016-0418-9","article-title":"Intracoronary versus Intravenous eptifibatide during percutaneous coronary intervention for acute ST-segment elevation myocardial infarction; a randomized controlled trial","volume":"32","author":"Sanati","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"key":"R28-58-20210226","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1540-8183.2007.00271.x","article-title":"Rheolytic thrombectomy during percutaneous coronary intervention improves long-term outcome in high-risk patients with acute myocardial infarction","volume":"20","author":"De Rosa","year":"2007","journal-title":"J Interv Cardiol"},{"key":"R29-58-20210226","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ijcard.2012.12.003","article-title":"Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials","volume":"168","author":"De Rosa","year":"2013","journal-title":"Int J Cardiol"},{"key":"R30-58-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.01.204","article-title":"Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction","volume":"208","author":"Sun","year":"2016","journal-title":"Int J Cardiol"},{"key":"R31-58-20210226","doi-asserted-by":"crossref","first-page":"e0129718","DOI":"10.1371\/journal.pone.0129718","article-title":"Efficacy and safety of intracoronary versus intravenous administration of tirofiban during percutaneous coronary intervention for acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"10","author":"Tang","year":"2015","journal-title":"PLoS One"},{"key":"R32-58-20210226","doi-asserted-by":"crossref","first-page":"e8223","DOI":"10.1097\/MD.0000000000008223","article-title":"Intralesional versus intracoronary administration of glycoprotein IIb\/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: a meta-analysis of randomized controlled trials","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine (Baltimore"},{"key":"R33-58-20210226","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cjca.2011.03.017","article-title":"Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials","volume":"27","author":"Sethi","year":"2011","journal-title":"Can J Cardiol"},{"key":"R34-58-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/1995-705X.102145","article-title":"High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The Tamip Study","volume":"13","author":"Balghith","year":"2012","journal-title":"Heart Views"},{"key":"R35-58-20210226","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2012.02.041","article-title":"Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials","volume":"222","author":"De Luca","year":"2012","journal-title":"Atherosclerosis"},{"key":"R36-58-20210226","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.ijcard.2013.05.033","article-title":"What accounts for the higher clinical efficacy of intracoronary abciximab?","volume":"168","author":"De Rosa","year":"2013","journal-title":"Int J Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:10:30Z","timestamp":1620961830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201805250-00058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":36,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010850","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}